好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Ethics, Pain, and Palliative Care

Thursday 04/14/11
03:00 PM - 04:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Ethics, Pain and Palliative Care
No CME available
Event Timeline
03:00 PM - 04:30 PM Abstract 002 - Attitudes towards Palliative and End-of-Life Care in ALS Patients and Providers
03:00 PM - 04:30 PM Abstract 003 - Tolerability and Safety of Gabapentin Extended-Release Tablets in the Treatment of Postherpetic Neuralgia
03:00 PM - 04:30 PM Abstract 004 - Relative Abuse Potential of Oxycodone HCl and Oxycodone HCl/Niacin Tablets in Non-Dependent Recreational Opioid Users
03:00 PM - 04:30 PM Abstract 005 - Substantial Nocebo Effect in Clinical Trials for Neuropathic Pain
03:00 PM - 04:30 PM Abstract 006 - Uninsured Patients Who Suffer a Stroke Present with More Severe Strokes and Have Longer Hospitalizations Than Insured Patients
Faculty Disclosures
Richard D. Brower, MD, FAAN No disclosure on file
Amanda C. Peltier, MD, MS Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.
No disclosure on file
Jane E. Howard, MD No disclosure on file
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Peter D. Donofrio, MD, FAAN No disclosure on file
Kenneth W. Sommerville, MD, FAAN No disclosure on file
Akash J. Patel No disclosure on file
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Dimos Dimitrios D. Mitsikostas, MD, PhD The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Angelo Antonini, MD Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Francine Arneson, MD No disclosure on file
Christopher D. Lee, MD Dr. Lee has nothing to disclose.
Martin Gizzi, MD, PhD, FAAN No disclosure on file
Dimitrios Papadopoulos, MD No disclosure on file
Michael Sweeney, MD No disclosure on file
Gordon A. Irving, MD No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Damian E. Berezovsky, MD No disclosure on file
Jad A. Dandashi No disclosure on file
Dinesh V. Jillella, MD Dr. Jillella has nothing to disclose.